
Melissa Hadley Barrett discusses real-world outcomes and tolerability of intranasal vardenafil for men with persistent erectile dysfunction despite prior standard therapy.
A reference on the key recommendations from the AUA Testosterone Deficiency guideline.
Testosterone deficiency has become a subject of national discussion in recent months. In July 2026, the US Department of Defense (DoD) announced it would begin annual testosterone deficiency screening for active-duty service members 30 years and older, with voluntary testing available to younger troops and testosterone replacement therapy (TRT) offered to those who screen positive and choose treatment.1






